Are these the final financial results for GE HealthCare and GE?

No, these are preliminary and unaudited financial results for GE HealthCare. The filing explicitly states that these results do not present all information necessary for a complete understanding of the earnings results for GE or GE HealthCare for the fiscal year ended December 31, 2022. Investors should await GE's official earnings webcast on January 24, 2023, for comprehensive and final results.

When will investors get a more complete picture of GE's financial performance?

Investors can expect a more complete picture of GE's financial performance during their scheduled earnings webcast on January 24, 2023, at 8:00 a.m. EST. This event will cover both the fourth quarter and the full fiscal year 2022.

What are the key risks and uncertainties mentioned in the filing?

The filing highlights several risks and uncertainties that could materially affect GE's future results. These include the success and timing of asset dispositions (such as the planned spin-off of GE Vernova and the sale of equity interests in AerCap and GE HealthCare), changing macroeconomic conditions (like inflation, supply chain disruptions, rising interest rates), and GE's de-leveraging and capital allocation plans.

GE 8-K: Earnings & Results

Q: What is the main purpose of this 8-K filing?

The main purpose of this filing is to announce that GE HealthCare Technologies Inc. has released preliminary, unaudited financial results for the fourth quarter and full fiscal year ended December 31, 2022. This information is being shared because GE HealthCare was part of GE's consolidated financial results before its separation.

Summary

This 8-K filing by General Electric (GE) primarily announces the preliminary, unaudited financial results for GE HealthCare Technologies Inc. for the fourth quarter and full fiscal year ended December 31, 2022. This information is being provided because GE HealthCare was a part of GE's consolidated results prior to its separation from GE on January 3, 2023. Investors should note that these are preliminary results and do not provide a complete picture of the full year's performance for either GE HealthCare or GE. The filing also serves as a notification for GE's upcoming fourth-quarter and full-year 2022 earnings webcast, scheduled for January 24, 2023. This webcast will be a crucial event for investors seeking a comprehensive understanding of GE's performance and outlook. The company reiterates its forward-looking statements disclaimer, emphasizing that actual results could differ materially due to various risks and uncertainties, including those related to asset dispositions, macroeconomic conditions, and GE's de-leveraging plans.

Key Highlights

1GE HealthCare released preliminary unaudited financial results for Q4 and FY 2022.
2These results are being furnished due to GE HealthCare's prior inclusion in GE's consolidated financials before its separation on January 3, 2023.
3The provided preliminary results are not exhaustive and do not represent complete financial statements.
4GE's official Q4 and FY 2022 earnings webcast is scheduled for January 24, 2023.
5The filing includes a standard forward-looking statements disclaimer, highlighting potential risks and uncertainties.
6Key risks mentioned include asset dispositions (e.g., GE Vernova spin-off, AerCap, GE HealthCare), macroeconomic factors (inflation, interest rates, supply chain), and GE's de-leveraging plans.

GENERAL ELECTRIC CO 8-K Report, Financial Results (Jan 10, 2023)

Summary

Key Highlights

Frequently Asked Questions